Thursday, September 24, 2020 10:43:26 AM
From broken contracts with weak companies, Medipharm learned they have to evolve their business model; now they are putting products out and going international with focus on medicinal.
ACB with miserable $1. I think 4? BILLION quarterly loss, well the newEST CEO says they have to go basically in same direction as Medipharm, create new products, find international partners/deals, etc, only they are losing so much money and falling so far behind, so quickly.
Makes MEDIF$ look prescient today and obviously we all hope they can report significant revenues from these recent deals in future quarters.
Also hopefully there is a point at which it is more risky to sell at these lows than hold on for good news from the new efforts.
glta
MEDIF$
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM